CO-CRYSTALS OF 5-AMINO-2-OXOTHIAZOLO[4,5-D]PYRIMIDIN-3(2H)-YL-5-HYDROXYMETHYL TETRAHYDROFURAN-3-YL ACETATE AND METHODS FOR PREPARING AND USING THE SAME
申请人:Hoffmann-La Roche Inc.
公开号:US20160176899A1
公开(公告)日:2016-06-23
Co-crystals of Formula I compounds and their pharmaceutical compositions are novel therapeutics for the treatment of diseases, such as human immunodeficiency virus (HIV) infection, hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection and cancer. The co-crystal are more stable to oxidation and aqueous degradation, have a better pharmacokinetic profile and superior biological activity than the corresponding tosylate salt form of Formula I compound.
Formula I化合物的共晶体及其药物组合物是治疗疾病的新型治疗药物,例如人类免疫缺陷病毒(HIV)感染、乙型肝炎病毒(HBV)感染、丙型肝炎病毒(HCV)感染和癌症。这些共晶体比Formula I化合物对应的对甲苯磺酸盐形式更稳定,对氧化和水解更稳定,具有更好的药代动力学特性和优越的生物活性。
Substituted pyridinyloxy(thio)phenyl-acetamides, -ureas and urea
申请人:The Dow Chemical Company
公开号:US04003734A1
公开(公告)日:1977-01-18
Disclosed are novel substituted pyridinyloxy(thio)phenyl-acetamides, -ureas and urea derivatives, N-oxide derivatives thereof, and certain novel intermediates therefore. The compounds of the instant invention are useful as herbicides and can be formulated to provide herbicidal compositions.
USE OF A LUBRICANT COMPOSITION FOR REDUCING KNOCKING
申请人:TOTAL MARKETING SERVICES
公开号:US20170051226A1
公开(公告)日:2017-02-23
The present disclosure relates to a lubricant composition including at least one base oil and at least one organic compound. The lubricant composition thus makes it possible to reduce, or even to eliminate knock in a vehicle engine, preferably a motor vehicle engine.